Parameters | Overall | CECS | EES | P |
---|---|---|---|---|
No. of patients | 50 | 27 | 23 | Â |
Mean age, years | 51.1 ± 15.01 | 50.5 ± 13.7 | 51.7 ± 16.8 | 0.772 |
Sex | – |  |  | 0.084 |
 Male (%) | 26 (52.0%) | 11 (40.7%) | 15 (65.2%) |  |
 Female (%) | 24 (48.0%) | 16 (59.3%) | 8 (34.8%) |  |
Mean BMI, kg/m2 | 25.1 ± 3.6 | 25.7 ± 3.4 | 24.4 ± 3.9 | 0.218 |
Hypertension (%) | 10 (20.0%) | 5 (18.5%) | 5 (21.7%) | 0.777 |
Diabetes (%) | 11 (22.0%) | 8 (29.6) | 3 (13.0%) | 0.158 |
Recurrent (%) | 12 (24.0%) | 8 (29.6%) | 4 (17.4%) | 0.313 |
Course, months (IQR) | 12 (3–24) | 12 (3–36) | 10 (3–12) | 0.144 |
Clinical presentation | ||||
 Visual impairment (%) | 46 (92.0%) | 25(92.6%) | 21(91.3%) | 0.867 |
 Bitemporal hemianopia (%) | 44 (88.0%) | 25 (92.6%) | 19 (82.6%) | 0.279 |
 Headache (%) | 20 (40.0%) | 10 (37.0%) | 10 (43.5%) | 0.643 |
 Preoperative hypopituitarism (%) | 24 (48.0%) | 17 (63.0%) | 16 (69.6%) | 0.623 |
 Diabetes insipidus (%) | 3 (6.0%) | 1 (3.7%) | 2 (8.7%) | 0.459 |
 Hydrocephalus (%) | 11 (22.0%) | 7 (25.9%) | 4 (17.4%) | 0.468 |
 Pituitary apoplexy (%) | 7 (14.0%) | 4 (14.8%) | 3 (13.0%) | 0.857 |
 Functioning PitNET (%) | 5 (10.0%) | 3 (11.1%) | 2 (8.7%) | 0.777 |